Movano (NASDAQ:MOVE) CFO Sells $597,134.08 in Stock

Movano Inc. (NASDAQ:MOVE) CFO Jeremy Cogan sold 28,736 shares of Movano stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $20.78, for a total value of $597,134.08. Following the transaction, the chief financial officer directly owned 60,504 shares in the company, valued at approximately $1,257,273.12. This trade represents a 32.20% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Jeremy Cogan also recently made the following trade(s):

• On Tuesday, January 6th, Jeremy Cogan sold 8,218 shares of Movano stock. The shares were sold at an average price of $7.79, for a total transaction of $64,018.22.
• On Monday, January 5th, Jeremy Cogan sold 1,879 shares of Movano stock. The stock was sold at an average price of $8.35, for a total transaction of $15,689.65.

Movano Stock Down 10.2%

Shares of MOVE stock opened at $17.13 on Friday. The stock’s 50-day moving average price is $9.56 and its 200 day moving average price is $8.05. Movano Inc. has a 52-week low of $4.67 and a 52-week high of $55.00. The stock has a market capitalization of $14.22 million, a PE ratio of -1.58 and a beta of 0.79.

Movano (NASDAQ:MOVE) last released its earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($7.00) by $2.27. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.The business had revenue of $0.08 million for the quarter, compared to analyst estimates of $3.88 million.

Movano News Roundup

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Short interest has fallen substantially in January, reducing one pool of bearish pressure and the chance of disorderly short‑covering volatility later.
• Positive Sentiment: Technical: the stock recently cleared its 200‑day moving average — a bullish technical milestone that can attract momentum buyers. Movano 200‑Day MA Article
• Neutral Sentiment: Liquidity/volatility: trading has seen multiple intraday LULD pauses and lower‑than‑average volume today, meaning price swings can be amplified by lighter order flow.
• Negative Sentiment: Insider selling: CEO John Mastrototaro sold 33,069 shares (~37% reduction in his holdings) at about $20.80. Filing: CEO SEC Filing
• Negative Sentiment: Insider selling: CFO Jeremy Cogan sold 28,736 shares (~32% reduction) at about $20.78. Filing: CFO SEC Filing
• Negative Sentiment: Fundamentals remain challenged: the company’s last quarter showed a sizable EPS beat on an accounting basis but essentially no revenue (reported $0.08M vs. consensus ~$3.9M) and extreme negative margins/ROE — keeps investor focus on cash burn and path to meaningful sales.
• Negative Sentiment: Analyst sentiment is weak: recent notes include downgrades / reiterated sell ratings from independent outlets, which can pressure the stock in a thin market. Weiss Ratings

Institutional Trading of Movano

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC purchased a new stake in shares of Movano Inc. (NASDAQ:MOVE) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano at the end of the most recent quarter. 16.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Movano in a research report on Thursday, January 22nd. Wall Street Zen cut shares of Movano from a “hold” rating to a “sell” rating in a research note on Saturday, January 17th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has an average rating of “Sell”.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.